SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-006074
Filing Date
2021-03-15
Accepted
2021-03-15 17:27:51
Documents
98
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20201231_10k.htm   iXBRL 10-K 2230403
2 EXHIBIT 4.1 ex_232263.htm EX-4.1 26823
3 EXHIBIT 10.17 ex_232262.htm EX-10.17 8212
4 EXHIBIT 10.18 ex_232264.htm EX-10.18 8662
5 EXHIBIT 21.1 ex_232194.htm EX-21.1 1590
6 EXHIBIT 23.1 ex_232195.htm EX-23.1 5545
7 EXHIBIT 31.1 ex_232196.htm EX-31.1 7652
8 EXHIBIT 31.2 ex_232197.htm EX-31.2 7674
9 EXHIBIT 32.1 ex_232198.htm EX-32.1 5243
  Complete submission text file 0001437749-21-006074.txt   9588245

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA acrx-20201231.xsd EX-101.SCH 96410
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20201231_cal.xml EX-101.CAL 57271
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20201231_def.xml EX-101.DEF 555801
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20201231_lab.xml EX-101.LAB 524853
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20201231_pre.xml EX-101.PRE 602766
15 EXTRACTED XBRL INSTANCE DOCUMENT acrx20201231_10k_htm.xml XML 1558191
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 21742652
SIC: 2834 Pharmaceutical Preparations